- Home
- FOXX vs HSCS Comparison
FOXX vs HSCS Comparison
Compare FOXX & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FOXX | HSCS |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3M | 15.8M |
| IPO Year | 2025 | 2022 |
Fundamental Metrics
Financial Performance| Metric | FOXX | HSCS |
|---|---|---|
| Price | $2.51 | $4.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.8K | ★ 145.5K |
| Earning Date | 09-28-2026 | 09-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.84 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $52,584,432.00 | $4,319.00 |
| Revenue This Year | N/A | $295.93 |
| Revenue Next Year | N/A | $18,321.05 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.71 | $1.63 |
| 52 Week High | $7.90 | $5.25 |
Technical Indicators
Market Signals| Indicator | FOXX | HSCS |
|---|---|---|
| Relative Strength Index (RSI) | 47.16 | 58.35 |
| Support Level | $2.39 | $1.84 |
| Resistance Level | $2.69 | $5.25 |
| Average True Range (ATR) | 0.17 | 0.51 |
| MACD | 0.01 | -0.08 |
| Stochastic Oscillator | 67.31 | 61.50 |
Price Performance
Historical ComparisonAbout FOXX Foxx Development Holdings Inc.
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.